XML 52 R30.htm IDEA: XBRL DOCUMENT v3.26.3
Stock-Based Compensation (Tables)
 3 Months Ended
Oct. 02, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes activity with respect to Company-issued stock options since July 3, 2026:
Options Outstanding
Number of
Shares		Weighted Average
Grant Date
Fair Value		Weighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate
Intrinsic Value
Outstanding at July 3, 2026934 $12.71 $45.00 — 
Granted— — 
Exercised(467)12.71 42.50 
Canceled— — 
Outstanding at October 2, 2026467 12.71 47.50 1.92 years$17,452 
Exercisable at October 2, 2026— $— $— — — 
Schedule of Restricted Stock Awards
The following table summarizes the status of the Company’s non-vested restricted stock unit awards and deferred stock unit awards since July 3, 2026:
Non-vested Restricted Stock Unit  Awards
Number of
Shares		Weighted Average
Grant Date
Fair Value
Non-vested at July 3, 20261,672 $45.50 
Granted220 115.52 
Vested(533)44.27 
Forfeited(31)51.48 
Non-vested at October 2, 20261,328 $70.24 
Schedule of Stock-Based Compensation Expense
The following table presents share-based compensation expenses included in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss):
First Quarters Ended
October 2, 2026September 26, 2025
Cost of revenues$1,146 $1,760 
Selling, general and administrative9,299 6,296 
Research and development1,726 1,517 
Stock-based compensation expense before tax12,171 9,573 
Income taxes(1)
(3,286)(2,585)
Stock-based compensation expense, net of income taxes$8,885 $6,988 
(1) Federal and state statutory rate of 27%